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Abstract	
Background:	 Data	 preparation,	 such	 as	 missing	 values	 imputation	 and	transformation,	 is	 the	 first	 step	 in	 any	 data	 analysis	 and	 requires	 crucial	 attention.	Particularly,	 analysis	 of	 metabolites	 demands	 more	 preparation	 since	 those	 small	compounds	 have	 recently	 been	 measurable	 in	 large	 scales	 with	 mass	 spectrometry	techniques.	 We	 introduce	 novel	 statistical	 techniques	 for	 metabolite	 missing	 values	imputation	by	utilizing	replication	samples.			
Results:	To	understand	the	nature	of	the	missing	values	using	replication	samples,	we	 obtained	 the	 empirical	 distribution	 of	missing	 values	 and	 observed	 that	 the	 rate	 of	missing	 values	 is	 approximately	 distributed	 as	 uniform	 across	 the	 metabolite	 range.	Therefore,	 the	 missing	 values	 cannot	 be	 imputed	 with	 the	 lowest	 values.	 Using	 the	identified	 distribution,	 we	 illustrated	 a	 simulation	 study	 to	 find	 an	 optimal	 imputation	approach	for	metabolites.	
Conclusions:	We	demonstrated	 that	 the	missing	 values	 in	metabolomic	data	 sets	might	not	be	necessarily	low	value.	After	identification	of	the	nature	of	missing	values,	we	validated	K	nearest	neighborhood	as	an	optimal	approach	for	imputation.		
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Background	Extracting	 relevant	 and	substantial	 biological	 information	 from	 large-scale	datasets	 at	different	biological	levels	is	one	of	the	challenges	in	modern	biomedical	research.		The	extraction	process	is	highly	dependent	 on	 data	 preparation,	 including	 imputation	 and	 data	 transformation	 to	 hold	 underlying	assumptions.	To	provide	a	valid	analysis,	missing	value	imputation	techniques	need	to	be	carefully	selected	since	using	inappropriate	imputation	approaches	results	in	a	loss	of	power	and	misleading	conclusions.	Therefore,	the	nature	of	missing	values	and	an	optimal	imputation	approach	need	to	be	identified	before	initiating	any	data	analysis.	
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Missing	 values	 widely	 occur	 in	 mass	 spectrometry	 metabolomics	 datasets	 due	 to	 a	 variety	 of	reasons,	such	as	values	that	exist	below	the	detection	limit	of	the	mass	spectrometer	or	technical	issues	unrelated	 to	 the	 metabolite	 processing	 [1-3].	 The	 first	 step	 of	 preprocessing	 raw	 metabolomic	 data	includes	baseline	correction,	noise	reduction,	smoothing,	peak	detection,	and	alignment	[4-7].	After	the	preprocessing	and	applying	stringent	quality	control	standards	 for	metabolite	 levels	by	 the	 laboratory,	some	other	steps	such	as	imputation	and	transformation	are	required	to	prepare	the	data	for	analysis.			Missing	 value	 imputation	 has	 been	 addressed	 through	 a	 wide	 range	 of	 approaches,	 including	disregarding	all	variables	with	missing	values	or	using	univariate,	multivariate,	Bayesian	approaches	[e.g.	1,	 6,	 8-9].	 Some	 studies	 highlight	 the	 importance	 of	 imputation	 of	 missing	 values	 in	 data	 processing	pipelines	by	demonstrating	the	major	effect	of	missing	data	estimation	algorithms	on	the	outcome	of	data	analysis	[e.g.	4,	10-11].	However,	imputing	metabolomic	missing	values	with	the	lowest	value	of	measured	metabolites	 is	 going	 to	 be	 a	 common	 approach.	 Therefore,	 new	 techniques	 are	 required	 for	 the	identification	of	 the	nature	of	missing	 values	 to	 emphasize	 the	 importance	of	 the	 choice	of	 imputation	approach.			To	identify	the	nature	of	missing	values,	we	take	advantage	of	the	availability	of	replication	samples	that	 occurs	 in	 many	 biomedical	 and	 biological	 studies.	 Using	 replication	 samples,	 we	 proposed	 new	statistical	techniques	to	obtain	the	empirical	distribution	of	missing	data.	Through	the	application	of	the	techniques	on	97	replication	samples	 in	metabolomics	data,	we	 identified	 the	empirical	distribution	of	missing	 values	 and	 showed	the	missing	 values	 are	not	under	 the	detection	 limit.	We	also	 conducted	a	simulation	study	based	on	the	identified	distribution	of	missing	values	for	1977	individuals	and	found	that	the	KNN	algorithm	performs	better	than	the	other	approaches.	The	result	of	this	study	provides	validation	to	other	studies	that	made	the	same	conclusion	through	different	approaches.		
Methods	and	Results	
Study	sample:	Our	metabolomic	data	were	collected	on	a	subset	of	 the	Atherosclerosis	Risk	 in	Communities	(ARIC)	study	(The	ARIC	Investigators	1989)	[12].	Metabolite	profiling	was	completed	in	June	2010	 using	 fasting	 serum	 samples	 that	 had	 been	 stored	 at	 -80°C	 since	 collection	 at	 the	 baseline	examination	in	1987–1989.	For	the	discovery	of	African-American	samples,	detection	and	quantification	of	metabolites	were	completed,	using	an	untargeted,	gas	chromatography-mass	spectrometry,	GC-MS,	and	liquid	 chromatography-mass	 spectrometry,	 LC-MS,	 based	metabolomic	quantification	protocol	 [13-14].	Pre-processing	of	the	raw	data,	including	baseline	correction,	noise	reduction,	smoothing,	peak	detection	alignment,	was	carried	out	by	Metabolon	Inc.,	and	608	metabolites	were	recorded	over	1977	individuals.	Since	the	source	of	missing	metabolomic	data	varies	from	biological	to	technical	reasons,	using	statistical	techniques	here,	we	focus	on	the	imputation	of	metabolites	that	have	50	percent	or	less	missing	values.		Based	 on	 the	 requirement	 for	 each	 stage	 of	 analysis,	we	 used	 a	particular	 subset	 of	 data	with	specific	features.		For	instance,	we	used	replication	samples	of	97	individuals	who	shared	159	metabolites	to	 identify	 the	 nature	 of	 missing	 values	 with	 a	 novel	 approach.	 Since	 these	 replication	 samples	were	acquired	4-5	years	apart,	we	first	determined	the	effect	of	4-5	years	longer	freezing	on	serum	metabolites.	We	note	here	that	the	metabolites	were	measured	from	frozen	serum	more	than	20	years,	which	may	have	already	 resulted	 in	 the	 loss	of	several	metabolites.	However,	we	wanted	 to	address	whether	4-5	 years	longer	freezing	(after	20	years	total	freezing)	has	a	significant	impact	on	metabolite	loss.	
	
Effect	of	 freezing:	By	comparing	 the	empirical	distributions	of	39	metabolites	with	no	missing	values	in	replication	set,	we	evaluated	whether	the	effect	of	longer	freezing	up	to	5	years	was	significant.	By	comparing	the	empirical	distributions	of	39	metabolites	with	no	missing	values	in	replication	set,	we	
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evaluated	whether	 the	 effect	 of	 longer	 freezing	 up	 to	 5	 years	was	 significant.	 To	 see	 if	 the	measured	metabolites	in	two	different	time	points	were	comparable	at	an	individual	level,	we	plotted	the	replication	samples	at	one	time	point	versus	the	other	time	point	for	each	metabolite,	Supplementary1.	The	plots	do	not	represent	any	significant	evidence	of	differences	or	trends	associated	with	the	time	points,	although	they	might	be	slightly	different.	We	employed	parametric	approaches	for	the	set	of	metabolites	that	were	normally	distributed	and	nonparametric	approaches	for	metabolites	that	were	not	normal.	For	the	set	of	metabolites	with	a	normal	distribution,	t-test	and	F-test	were	applied	to	assess	whether	the	distribution	of	a	metabolite	in	replication	samples	was	statistically	the	same.	For	the	set	of	non-normal	metabolites,	we	applied	the	two-sample	Kolmogorov-Smirnov	Test.	Using	these	approaches,	the	null	hypothesis	was	not	rejected	at	level	0.05,	which	means	there	is	no	significant	difference	between	metabolites	that	are	frozen	for	~20	years	and	those	that	are	frozen	for	4-5	years	longer	(~25	years).	Furthermore,	we	calculated	the	Kullback-Leibler	divergence	(KLD)	presented	for	each	metabolite	in	Supplementary1	that	ranges	from	0.02	to	0.271.	The	calculated	KLDs	close	to	zero	reveal	the	similar	distribution	of	replication	samples	at	both	time	points	which	are	inconsistency	with	the	other	results	and	plots.									
Empirical	distribution	of	missing	values:	Since	 the	missing	values	 in	each	metabolite	did	not	provide	enough	sample	 for	making	any	conclusion,	we	pooled	all	 the	missing	values	 that	are	observed	through	 replication	 to	 assess	 how	 they	 were	 distributed	 across	 the	 range	 of	 metabolites.	 In	 order	 to	provide	sufficient	conditions	that	allow	us	to	pool	missing	values,	we	carried	out	some	assessments.		The	 first	 assessment	 was	 related	 to	 the	 distribution	 of	 metabolites.	We	 noticed	 that	 different	transformations	were	required	to	transform	metabolites	to	normal	distribution.	Therefore,	we	selected	47	metabolites	 that	were	 normally	 distributed	 using	 the	 same	 transformation.	We	 then	 standardized	 the	metabolites	in	order	to	pool	their	missing	values.	The	second	assessment	was	related	to	the	missing	values	that	were	not	observed	in	any	replication.	Table1	shows	the	number	of	those	missing	values.	We	excluded	those	missing	values	from	the	analysis	at	this	step	and	reached	to	a	set	of	575	missing	values	imputed	with	replication	samples.	
							Table	1.	Number	of	missing	values	remained	non-observed	in	replication	samples.		Metabolite	 Trehalose	 Theophylline	 Stearoylcarnitine	 Phenylacetate	 Glycodeoxycholate	Non-observed	missing	values	 2	 4	 1	 3	 4			We	 pooled	 missing	 values	 across	 47	 metabolites	 normally	 distributed	 with	 the	 same	transformation	and	estimated	the	distribution	of	missing	values	using	Kolmogorov-Smirnov	Goodness-of-fit.	The	p-value	0.026	reveals	 that	 the	missing	values	are	approximately	normally	distributed,	Figure	1.	While	the	metabolites	had	been	transformed	to	the	normal	distribution,	we	calculated	the	rate	of	missing	values	in	the	same	intervals	obtained	based	on	quartile	of	missing	values.	We	observed	that	the	rate	of	missing	values	was	approximately	uniform	over	the	range	of	metabolite	values,	Figure	2.	Although,	the	rate	of	missing	values	in	the	first	quartile	is	slightly	higher	than	the	others.				
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Figure	1.	Distribution	of	missing	metabolites	observed	through	replication.	The	null	hypothesis	of	the	normal	distribution	of	missing	values	is	not	rejected	using	Kolmogorov-Smirnov	Goodness-of-fit	at	level	0.01.	The	assumption	that	metabolites	are	missing	because	they	are	low	is	not	supported	by	this	analysis.	Therefore,	 replacing	 missing	 values	 with	 the	 lowest	 values	 can	 severely	 distort	 the	 distribution	 of	metabolites	and	result	in	misleading	and	inaccurate	conclusions.				
	
Figure	2.	Rate	of	missing	values	across	the	range	of	metabolites.	Qi	in	x-axis	shows	ith	quartile	of	missing	values.	Y-axis	shows	the	rate	of	missing	values	in	each	interval.		We	 also	 plotted	 the	 empirical	 distribution	 of	 each	metabolite	 for	missing	 and	 observed	 values	separately.	Figure	3	demonstrates	the	distributions	for	three	metabolites,	while	the	distributions	of	the	entire	 set	 are	 provided	 in	 Supplementary2.	 The	 distributions	 showed	 that	 the	 missing	 values	 were	distributed	across	the	range	of	metabolites	and	were	not	only	low	values.			
	
Figure	3.	Blue:	empirical	distribution	of	observed	metabolites.	Red:	empirical	distribution	of	missing											metabolites.	The	captions	represent	the	name	of	metabolites	and	the	number	of	missing	values.	
	
An	 optimal	 approach	 for	 imputation:	 To	 obtain	 an	 optimal	 approach	 for	 imputation	 in	metabolomics	study,	we	conducted	a	cross	validation	based	analysis.	We	used	39	metabolites	measured	for	1977	individuals	who	had	no	missing	values.	While	the	distribution	of	the	rate	of	missing	values	over	a	
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range	 of	metabolites	 is	 approximately	 uniform,	 for	 each	metabolite,	we	 considered	 14	 equal	 intervals	across	the	range	of	metabolite	and	randomly	selected	10%	of	measured	metabolites	in	each	interval	(14	values)	and	set	them	as	missing	values.	To	impute	those	missing	values,	we	utilized	five	approaches	that	are	widely	applied:	Iterative	Robust	Model-based	Imputation	(IR-MI)	[15],	which	each	iteration	uses	one	variable	as	an	outcome	and	the	remaining	variables	as	predictors.	Multiple	Imputation	(MU-IM)	[16],	which	includes	multiple	imputations	of	incomplete	multivariate	data	values	in	place	of	missing	values	by	running	a	bootstrapped	EM	algorithm.	Maximum	Likelihood	estimation	for	multivariate	normal	data	(ML-ES)	[17],	which	is	focused	on	a	complete	variance/covariance	matrix	based	on	maximum	likelihood	values	imputed.	K	nearest	neighbor	(KNN)	[18],	which	assumes	data	are	missing	at	random	and	missing	data	depends	on	the	 observed	 data.	 The	 KNN	 approach	 is	 able	 to	 take	 advantage	 of	 multivariate	 relationships	 in	 the	completed	data.	Finally,	Random	Forest	approach	[19],	which	is	a	combination	of	tree	predictors	such	that	each	tree	depends	on	the	values	of	a	random	vector	sampled	independently	and	with	the	same	distribution	for	all	trees	in	the	forest.	For	imputation	using	these	approaches,	we	used	the	R	packages	irmi	[20],	amelia	[21],	Mvnmle	[22],	SeqKnn	[22],	and	missForest	[23]	respectively.	The	performance	of	these	methods	was	evaluated	in	terms	of	mean	square	imputed	errors	(MSIE)	of	40	times	repeated	simulation	scenario.	Among	those	methods,	the	KNN	algorithm,	which	uses	sequential	imputation,	outperformed	the	other	methods.	Although	it	was	slightly	better	than	RF,	it	remarkably	outperforms	the	other	approaches.	Figure	4	shows	the	 performance	 of	 the	models	 for	 K=5	 as	 the	 parameter	 of	 KNN,	 while	 K	 in	 (6	 to	 12)	 did	 not	 show	significant	differences	in	our	analysis.		KNN	 imputation	 based	 on	 correlation	 distance	 matrix	 is	 a	 simple	 but	 efficient	 approach	 that	attempts	 to	 preserve	 original	 data	 structure	 and	 avoids	 distorting	 the	 distribution	 of	 imputed	variables.	The	KNN	algorithm	starts	from	a	complete	subset	of	the	data	set,	Xc,	and	sequentially	estimates	the	missing	values	for	an	incomplete	observation,	x*,	by	minimizing	the	determinant	of	the	covariance	of	the	augmented	data	matrix,	X*	=	[Xc;	x’].	Then	the	observation	x*	is	added	to	the	complete	data	matrix,	and	the	algorithm	continues	with	the	next	observation	[24].			
	
Figure	4.	Performance	of	imputation	methods	as	a	function	of	MSIE.	Y-axes:	the	average	of	MSIE	over	40	sets	of	simulation.		As	mentioned,	 to	preserve	 characteristics	 and	 relationship	between	different	metabolites,	KNN	takes	into	account	the	correlation	among	metabolites	as	similarity	criteria.	To	assess	how	the	correlation	affects	 the	 imputation	performance,	we	 illustrated	 a	simulation	 analysis	similar	 to	 the	 aforementioned	scenario	for	a	set	of	metabolites	that	were	selected	with	different	correlation	cutoff	(0.5,	0.4,	0.3).	Figure	5	demonstrates	the	average	of	correlation	between	imputed	values	and	observed	values	of	metabolites	over	
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40	sets	of	simulation	for	each	cutoff.	Using	this	result,	we	imputed	metabolites	that	showed	at	least	30%	correlation	 with	 other	 metabolites	 and	 discarded	 the	 others	 from	 the	 analysis	 to	 avoid	 inaccurate	imputation.			
	
Figure	 5.	 Performance	 of	 the	 KNN	 algorithm	 for	 different	 correlation	 cutoff	 (x-axes)	 among	metabolites.	Y-axes:	the	average	of	correlation	among	imputed	and	observed	values	over	40	sets	of	simulation.		
	
	
Discussion	Identification	 of	 the	 nature	 of	missing	 values	 and	 imputation	 are	 the	major	 tasks	 in	 data	 pre-processing	since	no	presentation	of	metabolomic	data	analysis	is	complete	without	careful	consideration	of	missing	data.	The	aim	of	this	manuscript	was	to	introduce	novel	techniques	for	missing	value	imputation	by	 taking	 advantage	 of	 dozens-to-hundreds	 of	 replication	 samples.	 The	 introduced	 techniques	 can	 be	generalized	to	a	variety	of	studies,	although	we	applied	our	techniques	to	metabolomics	data.		Missing	 values	 widely	 occur	 in	 mass	 spectrometry	 metabolomics	 datasets	 due	 to	 a	 variety	 of	reasons,	 from	biology	 to	 totally	 technical	 reasons	 [1-3].	After	 the	pre-processing	of	metabolomics	data	including	baseline	correction,	noise	reduction,	smoothing,	peak	detection,	and	alignment	[4-7],	some	other	steps,	such	as	imputation	and	transformation,	are	required	to	prepare	the	data	for	analysis.	Missing	value	imputation	 has	 been	 addressed	 through	 a	 wide	 range	 of	 approaches.	 However,	 most	 attempts	 for	metabolomic	 imputation	 involve	 easy	 approaches,	 such	 as	using	 the	mean,	median,	 or	 lowest	value	of	measured	metabolites.	Each	data	set	is	unique,	and	missing	values	imputation	needs	to	be	carried	out	carefully.	In	this	study,	we	 introduced	 some	 statistical	 techniques	 for	 imputation	based	on	 the	 fact	 that	 some	data	 sets	include	replication	samples.	We	estimated	the	distribution	of	missing	values	in	a	set	of	97	individuals	with	replication	 samples	 and	 noticed	 that	 the	 rate	 of	 missing	 values	 across	 the	 range	 of	 metabolites	 was	approximately	 scattered	as	uniform.	The	 results	 contradict	 the	 common	belief	 that	missing	metabolite	values	 are	 low	values.	Therefore,	 replacing	missing	data	with	 the	 lowest	 value	 imposes	biases	 to	data	analyses.	 Furthermore,	 based	 on	 our	 assessments,	 we	 observed	 that	 different	 transformations	 were	required	for	different	metabolites	to	be	transformed	to	normal,	and	log	transformation	did	not	normalize	all	metabolites.	After	identifying	the	nature	of	missing	values	in	our	data	set,	we	conducted	a	simulation	study	to	compare	the	performance	of	different	imputation	approaches	and	identify	an	optimal	imputation	method.	To	this	end,	we	conducted	a	simulation	study	and	compared	five	different	imputation	methods,	IR-MI,	MU-
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IM,	ML-ES,	KNN,	and	RF	using	the	distribution	of	missing	values.	Through	this	study,	we	determined	the	performance	of	each	approach	and	selected	the	optimal	approach	for	imputation	of	metabolomics	data.	Among	 those	 five	 imputed	methods,	 the	 KNN	 algorithm	 showed	 the	 best	 performance	 for	metabolite	imputation.	After	preparing	 the	metabolomics	data	using	 the	 techniques	 introduced	here,	we	analyzed	
metabolomic data with the CCRS approach (a penalization approach for rare variant selection) [25-26] and the 
G-DAG algorithm (a systems approach established in Mendelian randomization and Bayesian graphical 
modeling) [27]. The results of the systematic analysis of the metabolites imputed here are provided in applications 
[28-32] with	clinically	validated	novel	findings	[33].				
Conclusion	Using	 replication	 samples,	 we	 could	 identify	 the	 nature	 of	 missing	 values	 through	 finding	 the	empirical	 distribution	 of	 metabolites.	 The	 result	 did	 not	 support	 the	 assumption	 that	metabolites	 are	missing	because	they	are	low.	Therefore,	replacing	missing	values	with	the	lowest	values	can	mislead	the	analysis	and	results	in	inaccurate	conclusions.	We	observed	that	the	rate	of	missing	values	is	approximately	distributed	as	uniform	across	the	range	of	metabolites.	Based	on	this	fact,	our	conducted	simulation	study	suggested	the	KNN	algorithm	as	an	optimal	approach	for	metabolomics	imputation.			
List	of	abbreviations	Kullback-Leibler	divergence	(KLD)	K	nearest	neighbor	(KNN)	Iterative	Robust	Model-based	Imputation	(IR-MI)	Multiple	Imputation	(MU-IM)	Maximum	Likelihood	estimation	for	multivariate	normal	data	(ML-ES)	Mean	square	imputed	errors	(MSIE)	Random	Forest	(RF)	
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